# Humacyte (HUMA) — Earnings

HUMA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/huma/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.16 |
| EPS estimate | −$0.10 |
| EPS surprise | −63.27% |
| Revenue surprise | −63.71% |
| Revenue | $406,000.00 |
| Revenue estimate | $1.1M |
| Reported | Aug 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1818382/000119312526347022/huma-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/a6b4fc3d-0f81-587c-fbca-73bc18482a71.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 12, 2026 | −$0.10 | −$0.16 | -63.27% | $1.1M | $406,000.00 |
| Q1 2026 | May 13, 2026 | −$0.12 | −$0.09 | 22.21% | $1.5M | $495,000.00 |
| Q4 2025 | Mar 27, 2026 | −$0.13 | −$0.13 | 1.29% | $1.3M | $467,000.00 |
| Q3 2025 | Nov 12, 2025 | −$0.15 | −$0.11 | 27.15% | $922,833.00 | $753,000.00 |
| Q2 2025 | Aug 11, 2025 | −$0.16 | −$0.24 | -48.33% | $1.0M | $301,000.00 |
| Q1 2025 | May 13, 2025 | −$0.19 | $0.28 | 246.83% | $764,833.00 | $517,000.00 |
| Q4 2024 | Mar 28, 2025 | −$0.25 | −$0.16 | 36.00% | — | — |
| Q3 2024 | Nov 8, 2024 | −$0.25 | −$0.33 | -32.48% | — | — |
| Q2 2024 | Aug 13, 2024 | −$0.24 | −$0.48 | -101.34% | — | — |
| Q1 2024 | May 10, 2024 | −$0.23 | −$0.29 | -28.38% | — | — |
| Q4 2023 | Mar 22, 2024 | −$0.24 | −$0.24 | 0.04% | $50,000.00 | — |
| Q3 2023 | Nov 9, 2023 | −$0.25 | −$0.25 | 1.61% | $66,667.00 | — |
| Q2 2023 | Aug 14, 2023 | −$0.22 | −$0.22 | -0.05% | $66,667.00 | — |
| Q1 2023 | May 12, 2023 | −$0.21 | −$0.36 | -71.35% | $155,600.00 | — |
| Q4 2022 | Mar 24, 2023 | −$0.23 | −$0.04 | 82.96% | $235,400.00 | $5,000.00 |
| Q3 2022 | Nov 10, 2022 | −$0.21 | −$0.25 | -16.66% | $203,500.00 | $31,000.00 |
| Q2 2022 | Aug 12, 2022 | −$0.22 | $0.35 | 260.70% | $235,400.00 | $1.3M |
| Q1 2022 | May 13, 2022 | −$0.21 | −$0.19 | 8.39% | $235,400.00 | $233,000.00 |
| Q4 2021 | Mar 29, 2022 | −$0.20 | $0.41 | 300.49% | $245,667.00 | $177,000.00 |
| Q3 2021 | Nov 12, 2021 | −$0.21 | −$0.72 | -251.22% | $371,667.00 | $241,000.00 |

## Frequently Asked Questions

### When did Humacyte (HUMA) last report earnings?

Humacyte last reported on Aug 12, 2026, covering fiscal Q2 2026.

### Did HUMA beat earnings estimates?

No. Humacyte reported EPS of −$0.16 for Q2 2026 against a −$0.10 estimate — a 63.27% miss.

### How much revenue did HUMA report last quarter?

Humacyte reported $406,000.00 in revenue for Q2 2026, against a consensus estimate of $1.1M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).